Dr Jeffery Becker is the CSO at Bexson Biomedical. Dr. Becker has over 20 years of research and clinical experience in NMDA-receptor pharmacology and clinical use. He was one of the first MDs in US administering and documenting ketamine for depression in the clinic, and is a world recognized speaker and expert in the clinical use of ketamine.
Explore more info with a membership (any level)
🧑 Extended profile information
📈 In-depth psychedelic reports (Sprout & Tree)
🪄 Weekly psychedelic research & implementation newsletter (free)